Expertise in
5
conditions

Dr. Kristina Goutsouliak

Hematology | Oncology
Grand Valley Oncology
688 23 1/2 Rd, 
Grand Junction, CO 
Offers Telehealth
Expertise in
5
conditions
Grand Valley Oncology
688 23 1/2 Rd, 
Grand Junction, CO 

Overview

Kristina Goutsouliak is a Hematologist and an Oncologist practicing medicine in Grand Junction, Colorado.

Dr. Goutsouliak is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Chronic Lymphocytic Leukemia (CLL), and Pseudomyxoma Peritonei.

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 6 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in CO

Hospital Affiliations

Intermountain Health St. Mary's Regional Hospital
Community Hospital
Montrose Regional Health
Moab Regional Hospital
Family Health West Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Rocky Mountain Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Grand Valley Oncology
688 23 1/2 Rd, Grand Junction, CO 81505

Additional Areas of Focus

Dr. Goutsouliak has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 02, 2026
Intervention Type: Other
Study Phase: Phase 3
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
A Randomized, Phase III Trial to Evaluate the Efficacy and Safety of Pembrolizumab (MK-3475) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer With >/= 1 CM Residual Invasive Cancer or Positive Lymph Nodes (ypN1mi, ypN1-3) After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: August 31, 2026
Intervention Type: Other, Radiation, Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 3
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Procedure, Biological, Drug, Radiation
Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine
Study Phase: Phase 2
The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib
The CompassHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): CompassHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared With T-DM1 and Tucatinib
Enrollment Status: Active_not_recruiting
Publish Date: June 15, 2026
Intervention Type: Other, Biological, Drug
Study Drugs: Trastuzumab Emtansine, Tucatinib
Study Phase: Phase 3
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Olanzapine With or Without Fosaprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)in Patients Receiving Highly Emetogenic Chemotherapy (HEC): A Phase III Randomized, Double Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)
An Observational Study to Collect and Assess Tissue Samples From Subjects With One of Three Neoplastic Conditions (ANSWer)
Enrollment Status: Completed
Publish Date: April 05, 2022
Intervention Type: Other
View 5 Less Clinical Trials

4 Total Publications

Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers.
Aromatase inhibitors and contralateral breast cancer in BRCA mutation carriers.
Journal: Breast cancer research and treatment
Published: December 10, 2021
Similar Doctors
Expertise in
22
conditions
Dr. Jonathan D. King
Hematology | Oncology
Expertise in
22
conditions
Dr. Jonathan D. King
Hematology | Oncology
Referral may be required

Grand Valley Oncology

688 23 1/2 Rd, 
Grand Junction, CO 
 (0.1 miles away)
970-644-3180
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan King is a Hematologist and an Oncologist practicing medicine in Grand Junction, Colorado. Dr. King is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Metastatic Pleural Tumor, Familial Pancreatic Cancer, Lung Cancer, and Pleuropulmonary Blastoma.

Expertise in
12
conditions
Expertise in
12
conditions
Referral may be required

Quest Diagnostics

750 Wellington Ave, 
Grand Junction, CO 
 (11.5 miles away)
970-298-7500
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Bradley Corr is an Oncologist practicing medicine in Grand Junction, Colorado. He has been practicing medicine for over 17 years. Dr. Corr is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Bladder Reconstruction, and Tissue Biopsy. Dr. Corr is currently accepting new patients.

Expertise in
16
conditions
Expertise in
16
conditions
Referral may be required

Bmt - Grand Valley Oncology

2596 F Rd, 
Grand Junction, CO 
 (11.5 miles away)
970-254-3180
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients

Daniel Couriel is a Hematologist practicing medicine in Grand Junction, Colorado. Dr. Couriel is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Multiple Myeloma, Chronic Graft Versus Host Disease (cGvHD), Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant. Dr. Couriel is board certified in American Board Of Internal Medicine. Dr. Couriel is currently accepting new patients.

Frequently Asked Questions about Dr. Kristina Goutsouliak

How do I make an appointment with Dr. Kristina Goutsouliak?

You can book an appointment with Dr. Kristina Goutsouliak by calling their office at 970-644-3180. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Kristina Goutsouliak a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Kristina Goutsouliak is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Kristina Goutsouliak specialize in?

While Dr. Kristina Goutsouliak is a Hematology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Chronic Lymphocytic Leukemia (CLL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Kristina Goutsouliak participate in research or clinical trials?

Yes. Dr. Kristina Goutsouliak has published 4 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Kristina Goutsouliak's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Kristina Goutsouliak accept my insurance?

Dr. Kristina Goutsouliak accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 970-644-3180 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goutsouliak's expertise for a condition
ConditionClose
    View All 82 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile